Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine

Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine

Inflammatory bowel diseases (IBDs) are chronic and disabling conditions that, uncontrolled, lead to irreversible bowel damage and associated comorbidities. Despite the new era of biological therapies, IBDs remain not curative. The treatment purpose is to induce endoscopic remission, reduce the progr...

Full description

Bibliographic Details
Main Authors: Arianna Dal Buono, Roberto Gabbiadini, Ludovico Alfarone, Virginia Solitano, Alessandro Repici, Stefania Vetrano, Antonino Spinelli, Alessandro Armuzzi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
sphingosine 1-phosphate
small molecules
oral therapy
ulcerative colitis
Crohn’s disease
Online Access:https://www.mdpi.com/2227-9059/10/7/1735

Internet

https://www.mdpi.com/2227-9059/10/7/1735

Similar Items